177 related articles for article (PubMed ID: 37509133)
21. The anti-proliferative effect of 2-[piperidinoethoxyphenyl]-3-[4-hydroxyphenyl]-2H-benzo(b) pyran is potentiated via induction of estrogen receptor beta and p21 in human endometrial adenocarcinoma cells.
Fatima I; Saxena R; Kharkwal G; Hussain MK; Yadav N; Hajela K; Sankhwar PL; Dwivedi A
J Steroid Biochem Mol Biol; 2013 Nov; 138():123-31. PubMed ID: 23688837
[TBL] [Abstract][Full Text] [Related]
22. The Co-Expression of Estrogen Receptors ERα, ERβ, and GPER in Endometrial Cancer.
Hojnik M; Sinreih M; Anko M; Hevir-Kene N; Knific T; Pirš B; Grazio SF; Rižner TL
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769338
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of endometrial carcinoma cell growth using antisense estrogen receptor oligodeoxyribonucleotides.
Taylor AH; al-Azzawi F; Pringle JH; Bell SC
Anticancer Res; 2002; 22(6C):3993-4003. PubMed ID: 12553024
[TBL] [Abstract][Full Text] [Related]
24. Expression and potential roles of pregnane X receptor in endometrial cancer.
Masuyama H; Hiramatsu Y; Kodama J; Kudo T
J Clin Endocrinol Metab; 2003 Sep; 88(9):4446-54. PubMed ID: 12970323
[TBL] [Abstract][Full Text] [Related]
25. [Effects of metformin on the estrogen-induced proliferation and the expression of ER in human endometrial cancer cells].
Zhang J; Zhang B; Yin Z; Chen F; Liu T; Xu H; Liu Y; Zhou X
Zhonghua Fu Chan Ke Za Zhi; 2014 Dec; 49(12):932-7. PubMed ID: 25608995
[TBL] [Abstract][Full Text] [Related]
26. Egr-1 regulates the transcriptional repression of mouse δ-aminolevulinic acid synthase 1 by heme.
Gotoh S; Nakamura T; Kataoka T; Taketani S
Gene; 2011 Feb; 472(1-2):28-36. PubMed ID: 21044876
[TBL] [Abstract][Full Text] [Related]
27. Estrogen receptors as potential therapeutic target in endometrial cancer.
Guha P; Sen K; Chowdhury P; Mukherjee D
J Recept Signal Transduct Res; 2023 Feb; 43(1):19-26. PubMed ID: 36883690
[TBL] [Abstract][Full Text] [Related]
28. Efp promotes in vitro and in vivo growth of endometrial cancer cells along with the activation of nuclear factor-κB signaling.
Sato W; Ikeda K; Urano T; Abe Y; Nakasato N; Horie-Inoue K; Takeda S; Inoue S
PLoS One; 2018; 13(12):e0208351. PubMed ID: 30586414
[TBL] [Abstract][Full Text] [Related]
29. Endometrial tumorigenesis in Pten(+/-) mice is independent of coexistence of estrogen and estrogen receptor α.
Joshi A; Wang H; Jiang G; Douglas W; Chan JS; Korach KS; Ellenson LH
Am J Pathol; 2012 Jun; 180(6):2536-47. PubMed ID: 22503752
[TBL] [Abstract][Full Text] [Related]
30. Anti-tumor effect of estrogen-related receptor alpha knockdown on uterine endometrial cancer.
Matsushima H; Mori T; Ito F; Yamamoto T; Akiyama M; Kokabu T; Yoriki K; Umemura S; Akashi K; Kitawaki J
Oncotarget; 2016 Jun; 7(23):34131-48. PubMed ID: 27153547
[TBL] [Abstract][Full Text] [Related]
31. Estrogen-related receptor-γ regulates estrogen receptor-α responsiveness in uterine endometrial cancer.
Yamamoto T; Mori T; Sawada M; Kuroboshi H; Tatsumi H; Yoshioka T; Matsushima H; Iwasaku K; Kitawaki J
Int J Gynecol Cancer; 2012 Nov; 22(9):1509-16. PubMed ID: 23051957
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of wild-type estrogen receptor beta and its isoforms: ER-beta/delta 5/6 i ER-beta/delta 6 in endometrial adenocarcinoma].
Witek A; Skałba P; Paul M; Graniczka M; Mazurek U; Chromy G; Wilczok T
Ginekol Pol; 2003 Sep; 74(9):897-902. PubMed ID: 14674142
[TBL] [Abstract][Full Text] [Related]
33. Urocortin suppresses endometrial cancer cell migration via CRFR2 and its system components are differentially modulated by estrogen.
Owens GL; Lawrence KM; Jackson TR; Crosbie EJ; Sayan BS; Kitchener HC; Townsend PA
Cancer Med; 2017 Feb; 6(2):408-415. PubMed ID: 28109061
[TBL] [Abstract][Full Text] [Related]
34. Effects of female sex hormones on clusterin expression and paclitaxel resistance in endometrial cancer cell lines.
Won YS; Lee SJ; Yeo SG; Park DC
Int J Med Sci; 2012; 9(1):86-92. PubMed ID: 22211095
[TBL] [Abstract][Full Text] [Related]
35. Estrogen receptor β: the guardian of the endometrium.
Hapangama DK; Kamal AM; Bulmer JN
Hum Reprod Update; 2015; 21(2):174-93. PubMed ID: 25305176
[TBL] [Abstract][Full Text] [Related]
36. Gankyrin plays an essential role in estrogen-driven and GPR30-mediated endometrial carcinoma cell proliferation via the PTEN/PI3K/AKT signaling pathway.
Zhang J; Yang Y; Zhang Z; He Y; Liu Z; Yu Y; Wu S; Cai B; Feng Y
Cancer Lett; 2013 Oct; 339(2):279-87. PubMed ID: 23142288
[TBL] [Abstract][Full Text] [Related]
37. Identification of a novel estrogen-regulated gene, EIG121, induced by hormone replacement therapy and differentially expressed in type I and type II endometrial cancer.
Deng L; Broaddus RR; McCampbell A; Shipley GL; Loose DS; Stancel GM; Pickar JH; Davies PJ
Clin Cancer Res; 2005 Dec; 11(23):8258-64. PubMed ID: 16322283
[TBL] [Abstract][Full Text] [Related]
38. Heterozygous disruption of ALAS1 in mice causes an accelerated age-dependent reduction in free heme, but not total heme, in skeletal muscle and liver.
van Wijk K; Akabane T; Kimura T; Saitoh S; Okano S; Kelly VP; Takagi M; Kodama K; Takahashi K; Tanaka T; Nakajima M; Nakajima O
Arch Biochem Biophys; 2021 Jan; 697():108721. PubMed ID: 33307066
[TBL] [Abstract][Full Text] [Related]
39. Estrogen receptor beta delta 6 (ER beta delta 6) isoform in human endometrial hyperplasia and adenocarcinoma.
Paul M; Cholewa K; Mazurek U; Witek A; Wilczok T
Cancer Invest; 2004; 22(2):211-8. PubMed ID: 15199603
[TBL] [Abstract][Full Text] [Related]
40. ATX‑LPA axis facilitates estrogen‑induced endometrial cancer cell proliferation via MAPK/ERK signaling pathway.
Zhang G; Cheng Y; Zhang Q; Li X; Zhou J; Wang J; Wei L
Mol Med Rep; 2018 Mar; 17(3):4245-4252. PubMed ID: 29328374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
